---
$id: https://graph.org.ai/products/commodity/51281663
$type: Product
source: UNSPSC
code: "51281663"
title: "Paromomycin sulfate"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Paromomycin sulfate

**UNSPSC Code**: 51281663
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H45N5O14.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 845NU6GJPS, chemically known as o-2,6-diamino-2,6-dideoxy-beta-l-idopyranosyl-(1->3)-o-beta-d-ribofuranosyl-(1->5)-o-(2-amino-2-deoxy-alpha-d-glucopyranosyl-(1->4))-2-deoxystreptamine sulfate (salt) but more generally known as paromomycin sulfate, which bears US NIH Compound Identifier 64144. European Medicines Agency schedules Paromomycin sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03654MIG. Most nations, for tariff and trade purposes, schedule paromomycin sulfate under HS 29419000 and SITC 54139. As of Q4 2014, PAROMOMYCIN SULFATE remains US FDA's Preferred Term for this commodity. Paromomycin sulfate bears US NLM identifiers UMLS ID C0733821 and NCI Concept Code C47652. SMILES: C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N.OS(=O)(=O)O.

